Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
CpG oligonucleotides: Novel regulators of osteoclast differentiation
W. E.I. Zou
, Harry Schwartz
, Stefan Endres
, Gunther Hartmann
,
Z. V.I. Bar-Shavit
Institute for Medical Research Israel-Canada (IMRIC)
Research output
:
Contribution to journal
›
Article
›
peer-review
58
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CpG oligonucleotides: Novel regulators of osteoclast differentiation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Osteoclast Differentiation
100%
Novel Regulator
100%
CpG ODN
100%
Tumor Necrosis Factor-α
27%
Osteoclastogenesis
27%
NF-B
18%
GM-CSF Receptor
18%
Bone Marrow Macrophages
18%
Macrophage Culture
18%
RANKL-induced Osteoclastogenesis
18%
Interleukin-1β
9%
Receptor Expression
9%
Macrophages
9%
Reduced Expression
9%
Specific Sequences
9%
Interleukin-1 Receptor Antagonist (IL-1Ra)
9%
Potential Therapeutics
9%
Oligodeoxynucleotide
9%
Therapeutic Tool
9%
Bacterial DNA
9%
Type I Receptor
9%
Bone Disease
9%
Murine Macrophages
9%
Sequence Context
9%
Downmodulation
9%
CpG Motif
9%
Calcitonin Receptor
9%
Multinucleation
9%
CG Dinucleotide
9%
Differentiation Pathways
9%
Immunology and Microbiology
Osteoclastogenesis
100%
CpG Oligodeoxynucleotide
100%
Tumor Necrosis Factor
40%
RANKL
40%
Macrophage
20%
Macrophage Culture
20%
Macrophage Colony-Stimulating Factor
20%
Interleukin 1 Receptor Antagonist
10%
Interleukin 1
10%
Murine
10%
Calcitonin
10%